G35.C0

Clinical Causes: Genetic predisposition: Family history may increase risk. Immune system dysfunction: Abnormal immune responses attack nerve fibers and myelin. Environmental factors: Low vitamin D levels, smoking, and certain infections could contribute. Initial relapsing-remitting phase: Transition from this pattern to progressive decline over time.

Key Symptoms: Gradual worsening of neurological functions Increased weakness or numbness in limbs Trouble with coordination and balance Blurred or double vision Problems with bladder or bowel control Chronic fatigue Cognitive changes such as difficulty concentrating Spasticity or muscle stiffness

Diagnosis Path: Diagnosis of secondary progressive MS involves a combination of neurological examinations, medical history, and imaging tests. Magnetic resonance imaging (MRI) is crucial in detecting lesions in the brain and spinal cord. Neurologists may also perform evoked potentials, cerebrospinal fluid analysis, and other assessments to monitor disease progression. Since SPMS involves a steady decline, tracking symptoms over time is essential for diagnosis. It is important to distinguish it from other forms of MS and neurological diseases.

Treatment Protocols: Disease-modifying therapies (DMTs): Certain medications may help delay progression. Symptom management: Medications, physical therapy, and occupational therapy to reduce spasticity, pain, and fatigue. Rehabilitation: Programs designed to improve mobility, strength, and daily functioning. Lifestyle adjustments: Regular exercise, balanced diet, and avoiding triggers that may exacerbate symptoms. Supportive care: Psychological support, counseling, and community resources to address emotional and social needs.